rs138672528
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_144773.4(PROKR2):c.343G>A(p.Val115Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000285 in 1,614,164 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000029 ( 0 hom. )
Consequence
PROKR2
NM_144773.4 missense
NM_144773.4 missense
Scores
8
6
5
Clinical Significance
Conservation
PhyloP100: 7.83
Genes affected
PROKR2 (HGNC:15836): (prokineticin receptor 2) Prokineticins are secreted proteins that can promote angiogenesis and induce strong gastrointestinal smooth muscle contraction. The protein encoded by this gene is an integral membrane protein and G protein-coupled receptor for prokineticins. The encoded protein is similar in sequence to GPR73, another G protein-coupled receptor for prokineticins. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.81
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PROKR2 | NM_144773.4 | c.343G>A | p.Val115Met | missense_variant | 2/3 | ENST00000678254.1 | NP_658986.1 | |
PROKR2 | XM_017027646.2 | c.343G>A | p.Val115Met | missense_variant | 2/4 | XP_016883135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PROKR2 | ENST00000678254.1 | c.343G>A | p.Val115Met | missense_variant | 2/3 | NM_144773.4 | ENSP00000504128 | P1 | ||
PROKR2 | ENST00000217270.4 | c.343G>A | p.Val115Met | missense_variant | 2/3 | 1 | ENSP00000217270 | P1 | ||
PROKR2 | ENST00000678059.1 | c.235G>A | p.Val79Met | missense_variant | 2/3 | ENSP00000503366 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152172Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251458Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135912
GnomAD3 exomes
AF:
AC:
8
AN:
251458
Hom.:
AF XY:
AC XY:
7
AN XY:
135912
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1461874Hom.: 0 Cov.: 34 AF XY: 0.0000344 AC XY: 25AN XY: 727246
GnomAD4 exome
AF:
AC:
43
AN:
1461874
Hom.:
Cov.:
34
AF XY:
AC XY:
25
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74464
GnomAD4 genome
AF:
AC:
3
AN:
152290
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
4
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Hypogonadotropic hypogonadism 3 with or without anosmia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 2008 | - - |
PROKR2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 29, 2024 | The PROKR2 c.343G>A variant is predicted to result in the amino acid substitution p.Val115Met. This variant has been reported in the heterozygous state along with a PROK2 variant in individuals with Kallmann syndrome (Cole et al. 2008. PubMed ID: 18559922; Table S3, Miraoui et al. 2013. PubMed ID: 23643382). Functional studies revealed that this variant exhibits loss of function in three signaling assays when tested alone, however, in at least one signaling assay it could be rescued by WT co-transfection, which is inconsistent with a deleterious effect in the heterozygous state (Table S2, Cox et al. 2018. PubMed ID: 29161432). This variant is reported in 0.023% of alleles in individuals of South Asian descent in gnomAD. Although we suspect this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D
M_CAP
Benign
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Pathogenic
Sift
Uncertain
D
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at